Clinical Value of Artificial Intelligence in the Diagnosis of Pulmonary Nodules
1.Department of Respiratory Medicine,Third Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China
2.Department of Intensive Care Unit,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China
*Corresponding author:LIU Jingyu,Professor,Chief physician,Master supervisor;E-mail:liujingyu0416@163.com
[1]FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.DOI:10.1002/ijc.29210.
[2]中华医学会放射学分会心胸学组.低剂量螺旋CT肺癌筛查专家共识[J].中华放射学杂志,2015,9(5):328-335.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx201505004.
[3]MASSALHA S,CLARKIN O,THORNHILL R,et al.Decision support tools,systems,and artificial intelligence in cardiac imaging[J].Can J Cardiol,2018,34(7):827-838.DOI:10.1016/j.cjca.2018.04.032.
[4]中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2018年版)[J].中华结核和呼吸杂志,2018,41(10):763-771.DOI:10.3760/cma.j.issn.1001-0939.2018.10.004.http://d.old.wanfangdata.com.cn/Periodical/zhjhhhx201810004.
[5]华琳,阎岩,张建.关于对诊断一致性Kappa系统的探讨[J].数理医药学杂志,2006,19(5):518-520.DOI:10.3969/j.issn.1004-4337.2006.05.033.
HUA L,YAN Y,ZHANG J.The discussion on Kappa coefficient for diagnosis coherence[J].Journal of Mathematical Medicine,2006,19(5):518-520.DOI:10.3969/j.issn.1004-4337.2006.05.033.
[6]权威发布:数据“说”肺癌[J].实用心脑肺血管病杂志,2019,27(9):7.http://www.cnki.com.cn/Article/CJFDTotal-SYXL201909003.htm.
[7]ZENG H,ZHENG R,GUO Y,et al.Cancer survival in China,2003—2005:a population-based study[J].Int J Cancer,2015,136(8):1921-1930.DOI:10.1002/ijc.29227.
[8]MACMAHON H,NAIDICH D P,GOO J M,et al.Guidelines for management of incidental pulmonary nodules detected on ct images:from the fleischner society 2017[J].Radiology,2017,284(1):228-243.DOI:10.1002/ijc.29227.
[9]TRAVIS W D,BRAMBILLA E,NOGUCHI M,et al.International association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma[J].J Thorac Oncol,2011,6(2):244-285.DOI:10.1097/JTO.0b013e318206a221.
[10]吴晓华,马大庆,张忠嘉,等.多层螺旋CT胸部低剂量扫描发现肺结节的临床研究[J].中华放射学杂志,2004,38(7):767-770.http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhfsx200407022.
[11]萧毅,刘士远.肺结节影像人工智能技术现状与思考[J].肿瘤影像学,2018,27(4):249-252.DOI:10.19732/j.cnki.1008-617X.2018.04.001.
XIAO Y,LIU S Y.Current status and thinking on artificial intelligence technology in pulmonary nodule imaging[J].Oncoradiology,2018,27(4):249-252.DOI:10.19732/j.cnki.1008-617X.2018.04.001.
[12]HOSNY A,PARMAR C,QUACKENBUSH J,et al.Artificial intelligence in radiology[J].Nat Rev Cancer,2018,18(8):500-510.DOI:10.1038/s41568-018-0016-5.
[13]刘士远,萧毅.基于深度学习的人工智能对医学影像学的挑战和机遇[J].中华放射学杂志,2017,51(12):899-901.http://d.old.wanfangdata.com.cn/Periodical/zhfsx201712002.
[14]PARK W J,PARK J B.History and application of artificial neural networks in dentistry[J].Eur J Dent,2018,12(4):594-601.DOI:10.4103/ejd.ejd-325-18.
[15]刘晓鹏,周海英,胡志雄,等.人工智能识别技术在T1期肺癌诊断中的临床应用研究[J].中国肺癌杂志,2019,22(5):319-323.DOI:10.3779/j.issn.1009-3419.2019.05.09.
LIU X P,ZHOU H Y,HU Z X,et al.Clinical application of artificial intelligence recognition technology in the diagnosis of stage T1 lung cancer[J].Chinese Journal of Lung Cancer,2019,22(5):319-323.DOI:10.3779/j.issn.1009-3419.2019.05.09.
[16]高云姝,周洁,潘军,等.人工智能技术在肺部肿瘤中的研究现状和应用前景[J].第二军医大学学报,2018,39(8):834-839.DOI:10.16781/j.0258-879x.2018.08.0834.
GAO Y S,ZHOU J,PAN J,et al.Research status and application prospect of artificial intelligence technology in lung tumors[J].Academic Journal of Second Military Medical University,2018,39(8):834-839.DOI:10.16781/j.0258-879x.2018.08.0834.
[17]TAKENAKA M,URAMOTO H,SHIMOKAWA H,et al.Discriminative features of thin-slice computed tomography for peripheral intrapulmonary lymph nodes[J].Asian J Surg,2013,36(2):69-73.DOI:10.1016/j.asjsur.2012.11.005.
[12]BORLAUG B A,OLSON T P,LAM C S,et al.Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction[J].J Am Coll Cardiol,2010,56(11):845-854.DOI:10.1016/j.jacc.2010.03.077.
[13]LIM S L,BENSON L,DAHLSTR?M U,et al.Association between use of long-acting nitrates and outcomes in heart failure with preserved ejection fraction[J].Circ Heart Fail,2017,10(4):e003534.DOI:10.1161/CIRCHEARTFAILURE.116.003534.
[14]SCHWARTZENBERG S,REDFIELD M M,FROM A M,et al.Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy[J].J Am Coll Cardiol,2012,59(5):442-451.DOI:10.1016/j.jacc.2011.09.062.
[15]VON LUEDER T G,ATAR D.Comorbidities and polypharmacy[J].Heart Fail Clin,2014,10:367-372.DOI:10.1016/j.hfc.2013.12.001.
[16]MüNZEL T,DAIBER A,GORI T.Nitrate therapy:new aspects concerning molecular action and tolerance[J].Circulation,2011,123(19):2132-2144.DOI:10.1161/CIRCULATIONAHA.110.981407.
[17]BORLAUG B A,KOEPP K E,MELENOVSKY V.Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejective fraction[J].J Am Coll Cardiol,2015,66(15):1672-1682.DOI:10.1066/j.jacc.2015.07.067.
[18]ZAMANI P,TAN V,SOTO-CALDERON H,et al.Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction[J].Circ Res,2017,120(7):1151-1161.DOI:10.1161/CIRCRESAHA.116.309832.
[19]BORLAUG B A,REDFIELD M M.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum[J].Circulation,2011,123(18):2006-2013.DOI:10.1161/CIRCULATIONAHA.110.954388.
[20]中国康复医学会心血管病专业委员会,中国老年学学会心脑血管病专业委员会.慢性稳定性心力衰竭运动康复中国专家共识[J].中华心血管病杂志,2014,42(9):714-720.DOI:10.3760/cma.j.issn.0253-3758.2014.09.002.http://d.old.wanfangdata.com.cn/Periodical/zhxxgb201409002.